HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis.

Front Cell Dev Biol · 2021 · PMC8526849 · PMID 34692687

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

In a dose-response analysis using the individual-level data, an overall trend for a progressive reduction in risk of ankylosing spondylitis was observed when given a stepwise increase in the number of inherited exposure alleles ( P value for trend = 0.020) or in the value of the HMGCR score ( P value for trend = 0.046) ( Figure 2 ).

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.